Treatment was initiated at 36 mg/day and patients continued with incremental increases of eighteen mg/day (36 to 108 mg/day) according to meeting particular enhancement standards with suitable tolerability. At the final study stop by, suggest transform scores (LS Signify, SEM) to the investigator rating to the AISRS demonstrated that CONCERTA was s